The Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) seeks a postdoctoral researcher to expand preclinical validation of a proprietary immunotherapy developed at IQAC, a peptide-drug conjugate called MACTIDE-V. This conjugate reprograms tumor-associated macrophages, unleashing potent immunostimulation and anti-metastatic activity in metastatic triple-negative breast cancer in mice.

The Pasqual Maragall Foundation opens a new call in partnership with the Alzheimer’s Association, the largest nonprofit funder of Alzheimer’s and dementia research.